GOLDSMITH MARK A sold RVMD
March 17, 2026 · Form 4 insider transaction
GOLDSMITH MARK A sold 12,871 shares of Revolution Medicines, Inc. at $99.48 per share, a transaction worth $1.28M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,871
Price
$99.48
Total value
$1.28M
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 19, 2026
Shares owned after276,698
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.; Includes 201,150 RSUs.